Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThe European Commission (EC) has published a guideline on Good Lay Summary Practice"(GLSP). The guideline was adopted by the Clinical Trials Expert Group (CTEG) of the EU Commission, which is composed of representatives of ethics committees and national competent authorities.
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 29 November - 2 December 2021
Additional guidance on requesting a UK PSMF number was added on 30th November 2021.
EMA - Publication of Article on Real-World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 3-4 November 2021
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 October 2021
Regulatory update - EMA encourages companies to submit type I variations for 2021 in November 2021
Repurposing of authorised medicines: pilot to support not-for-profit organisations and academia
The UK GLPMA hold periodic meetings with stakeholders. The minutes of the last meeting can be found here UK GLPMA Consultative committee meeting minutes May 2021
Medicines: licensing time-based performance measures